4D Molecular Therapeutics, Inc.
FDMTNASDAQHealthcare● Active
$8.60
$-0.04(-0.46%)
Market Cap$449575784
P/E Ratio—
52W High$12.34
52W Low$3.68
4D Molecular Therapeutics, Inc.（FDMT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · FDMT · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $85.21M | $0.04M | $20.72M | $3.13M | $18.04M |
| Cost of Revenue | $7.63M | $0.00M | $97.10M | $80.25M | $61.36M |
| Gross Profit | $77.58M | $0.04M | ($76.37M) | ($77.12M) | ($43.32M) |
| Gross Margin %(computed) | 91.05% | 100.00% | -368.54% | — | -240.17% |
| Operating Expenses | |||||
| R&D Expenses | $195.70M | $141.30M | $97.10M | $80.25M | $61.36M |
| G&A Expenses | $49.06M | $46.58M | $36.49M | $32.91M | $28.01M |
| Total Operating Expenses | $237.13M | $187.88M | $36.49M | $32.91M | $28.01M |
| Operating Income | ($159.55M) | ($187.84M) | ($112.87M) | ($110.03M) | ($71.33M) |
| Operating Margin %(computed) | -187.24% | — | -544.65% | — | -395.46% |
| Interest Income | $19.48M | $27.05M | $12.21M | $2.57M | $0.14M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($140.11M) | ($160.87M) | ($100.84M) | ($107.49M) | ($71.32M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($140.11M) | ($160.87M) | ($100.84M) | ($107.49M) | ($71.32M) |
| Net Margin %(computed) | -164.43% | — | -486.59% | — | -395.37% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.42 | $-2.98 | $-2.58 | $-3.12 | $-2.46 |
| Wtd Avg Shares | 57.93M | 53.94M | 39.13M | 32.35M | 27.73M |
| EBITDA | ($151.92M) | ($181.14M) | ($108.66M) | ($107.63M) | ($69.81M) |
| EBITDA Margin %(computed) | -178.29% | — | -524.36% | — | -387.02% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解4D Molecular Therapeutics, Inc.
关于4D Molecular Therapeutics, Inc.（FDMT）损益表
4D Molecular Therapeutics, Inc.（FDMT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，FDMT实现营收$0.09B，毛利润$0.08B（毛利率91.05%），净利润($0.14B)（净利率-164.43%）。
常见问题
FDMT · 4 问4D Molecular Therapeutics, Inc.（FDMT）2025财年营收为$0.09B，同比up230194.6%。
FDMT revenueFDMT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08